Vancomycin-resistant Enterococcus raffinosus: Molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program

Diagnostic Microbiology and Infectious Disease

Volumn 29, Issue 1, 1997, Pages 43-49

  Wilke, Werner W ^a   Marshall, Steven A ^a   Coffman, Stacy L ^a   Pfaller, Michael A ^a   Edmund, Michael B ^b   Wenzel, Richard P ^b   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; METICILLIN; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; VANCOMYCIN;

EID: 0030734432     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00059-X     Document Type: Article

References (30)

1. Appel GB, Neu HC (1977) The nephrotoxicity of antimicrobial agents. N Engl J Med 296:722-728.
2. Arthur M, Reynolds PE, Depardieu F, Evers S, Dutka-Malen S, Quintiliani R, Courvalin P (1996) Mechanisms of glycopeptide resistance in enterococci. J Infect Dis 32:11-16.
3. Bates J, Jordens ZJ, Griffiths DT (1994) Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 34:507-516.
4. Blanchard MM, Taillon-Miller P, Nowotny P, Nowotny V (1993) PCR buffer optimization with uniform temperature regimen to facilitate automation. PCR Method Applicat 2:234-240.
5. Cooper GL, Given DB (1986) Vancomycin: A Comprehensive Review of 30 Years of Clinical Experience. New York: Parker Row Publishers, Chapter 1, pp 1-5; Chapter 2, pp 2-21.
6. Dutka-Malen S, Evers S, Courvalin P (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33:24-27.
7. Facklam RR, Collins MD (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27:731-734.
8. Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RC, Thornsberry C, Enterococcal Study Group, Jarvis WR, Tenover FC (1992) Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 30:2373-2378.
9. Jones RN, Kehrberg EN, Erwin ME, Anderson SC, and the Fluoroquinolone Resistance Surveillance Group (1994) Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. I. Study on the threat of emerging resistances: Real or perceived? Diagn Microbiol Infect Dis 19:203-215.
10. Jones RN, Pfaller M, Marshall S, Erwin M, Edmond M, Wenzel R, and the SCOPE Study Group (1996) Nosocomial enterococcal blood stream infections (NEBSI) in the SCOPE Survey: Drug resistance, species occurrence and identification accuracy. In Abstracts of the IDSA 34th Annual Meeting, San Francisco, CA.
11. Jones RN, Sader HS, Erwin ME, Anderson SC, the Enterococcus Study Group (1995) Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Diagn Microbiol Infect Dis 21:85-93.
12. Kremery Jr V, Spanik S, Trupl J (1996) First report of vancomycin-resistant Streptococcus mitis bacteremia in a leukemic patient after prophylaxis with quinolones and during treatment with vancomycin. J Chemother 8:325-326.
13. LeClercq R, Derlot E, Duval J, Courvalin P (1988) Plasmidmediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319:157-161.
14. National Committee for Clinical Laboratory Standards (1993) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard M7-A3. Villanova, PA: National Committee for Clinical Laboratory Standards.
15. National Committee for Clinical Laboratory Standards (1995) Approved Standards. Performance Standards for Antimicrobial Susceptibility Testing. 6th Information Supplement M100-S6. Wayne, PA: National Committee for Clinical Laboratory Standards.
16. Newfield P, Roizen MF (1979) Hazards of rapid administration of vancomycin. Ann Intern Med 91:581.
17. Pfaller M, Hollis RJ, Sader HS (1992) PFGE of chromosomal DNA. Clinical Microbiology Procedures Handbook. Ed, Isenberg HD, Washington, DC: American Society for Microbiology, pp 10.3.1.
18. Pfaller M, Wendt C, Hollis RJ, Wenzel RP, Fritschel SJ, Neubauer JJ, Herwaldt LA (1996) Comparative evaluation of an automated ribotyping system versus pulsed field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent Gram-negative bacteremia. Diagn Microbiol Infect Dis 25:1-8.
19. Pfeiffer RR (1981) Structural features of vancomycin. Rev Infect Dis 3:205-209.
20. Poyart C, Pierre C, Quesne G, Pron B, Berche P, Trieu-Cuot P (1997) Emergence of vancomycin resistance in the genus Streptococcus: Characterization of a van B transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 41:24-29.
21. Rosato A, Pierre J, Billot-Klein D, Buu-Hol A, Gutmann L (1995) Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistance Enterococcus avium. Antimicrob Agents Chemother 39:830-833.
22. Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN (1994) Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol 32:2840-2842.
23. Sader HS, Biedenbach D, Jones RN (1995) Evaluation of Vitek and API 20S for species identification of enterococci. Diagn Microbiol Infect Dis 22:315-319.
24. Sapico FL, Canawati HN, Ginunas VJ, Gilmore DS, Montgomery JZ, Tuddenham WJ, Facklam RR (1989) Enterococci highly resistant to penicillin and ampicillin: An emerging clinical problem? J Clin Microbiol 27:2091-2092.
25. Schneierson SS, Amsterdam D (1957) In vitro sensitivity of erythromycin-resistant strains of staphylococci and en-terococci to vancomycin and novobiocin. Antibiot Chemother 7:251-254.
26. Singer DA, Jockimsen EM, Gielerak P, Jarvis WR (1996) Pseudo-outbreak of Enterococcus durans infections and colonization associated with introduction of an automated identification system software update. J Clin Microbiol 34:2685-2687.
27. Sorrell TC, Packham DR, Shanker S, Foldes M, Munroe R (1982) Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med 97:344-350.
28. Utterly AHC, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J (1989) High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 103:173-181.
29. Wilke WW, Sutton LD, Jones RN (1995) Automation of polymerase chain reaction tests to achieve acceptable contamination rates. Clin Chem 41:622-623.
30. Woodford N, Johnson AP, Morrison D, Speller DCE (1995) Current perspectives on glycopeptide resistance. Clin Microbiol Rev 8:585-615.